A lab technician marks a test tube in a lab
  • Creating value for our company, our shareholders and society


We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.

Novartis Investors Event Calendar

View recent presentations and learn more about upcoming events.

January 26, 2021
Basel, Switzerland
Fourth Quarter and Full Year Results 2020 and Annual Report 2020 publication

Learn More

Novartis COVID-19 Information Center

Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.

Enter the Information Center

Read the Novartis Frequently Asked Questions on COVID-19 (PDF 0.2 MB)

Environmental, Social and Governance (ESG)

Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen.

Learn More

We have created a set of environmental, social and governance indices to signpost where our key disclosures can be found across our publications and channels. Novartis aims to report comprehensively and transparently for all stakeholders concerned with ESG topics.

Explore the ESG Indices

ESG Updates: October 28, 2020 (PDF 0.5 MB)July 24, 2020 (PDF 0.6 MB) | April 29, 2020
Latest updates: Novartis Enterprise Risk Management (PDF 0.2 MB)  | Materiality Assessments Webinars

Share Price

  • SIX


    as of Jan 22, 17:30 CET

    +0.32 (+0.37%)

  • NYSE


    as of Jan 22, 16:00 EST

    +0.02 (+0.02%)

View stock performance
Featured Publications and Recent News

Novartis Clinical Pipeline

Our broad portfolio and strong pipeline help us offset the recurring impact of patent expirations for key products.

Explore Our Pipeline

Investor Relations Contacts

For questions about investor relations or the share registry, please contact our team.

Novartis AG

Lichtstrasse 35
CH-4056 Basel, Switzerland